Dosage device
Latest Novartis AG Patents:
- N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B
- Methods of treating dry eye disease using TNF alpha antagonists
- SELECTIVE BCL-XL PROTAC COMPOUNDS AND METHODS OF USE
- Process of manufacture of a compound for inhibiting the activity of SHP2, as well as products resulting from acid addition
- NLRP3 inflammasome inhibitors
Description
FIG. 1 is a front elevational view of a dosage device showing our new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a right side elevational view thereof;
FIG. 4 is a left side elevational view thereof;
FIG. 5 is a front elevational view of a second embodiment of a dosage device showing our new design;
FIG. 6 is a left side elevational view thereof;
FIG. 7 is a rear elevational view thereof; and,
FIG. 8 is a right side elevational view thereof.
Claims
The ornamental design for a dosage device, as shown and described.
Referenced Cited
Patent History
Patent number: D474841
Type: Grant
Filed: Jan 23, 2002
Date of Patent: May 20, 2003
Assignee: Novartis AG (Basel)
Inventors: Phil T. Price (Oxford), Stephanie Bley (Basel), Bernard Sams (London)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: John D. Thallemer
Application Number: 29/154,433
Type: Grant
Filed: Jan 23, 2002
Date of Patent: May 20, 2003
Assignee: Novartis AG (Basel)
Inventors: Phil T. Price (Oxford), Stephanie Bley (Basel), Bernard Sams (London)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: John D. Thallemer
Application Number: 29/154,433
Classifications
Current U.S. Class:
Hand Manipulated Tool Or Instrument (23) (D24/133);
Pipette Or Burette (D24/222)
International Classification: 2402;
International Classification: 2402;